Abstract:
The present invention provides single molecule analyses of species of use in analytical, diagnostic or prognostic assays. In exemplary embodiments, the assays utilize samples prepared by novel methods, affording assays of unexpected sensitivity and robustness. The method is described in a non-limiting manner by reference to cytokine assays.
Abstract:
Disclosed are methods, kits, and compositions for fluorescent detection of single biomolecules, e.g. proteins, using highly sensitive fluorescent dyes and a flow cell with one interrogation space for irradiation by focused lase r beam. The methods, kits, and compositions are useful in determining concentrations of molecules in samples to levels of 1 femtomolar, 1 attomola r, or lower. The methods, kits, and compositions also allow the determination o f concentration over a wide range, e.g., 7-log range, without need for sample dilution.
Abstract:
The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin. Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.
Abstract:
The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin, Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin. WO 2007/114947 PCT/US2007/008506 30 3 7 0 630 5 Figure 1A
Abstract:
Un método para determinar una enfermedad cardiovascular en un individuo que comprende: (a) medir la concentración en suero o plasma de la troponina cardiaca a partir de una muestra de sangre del individuo; (b) comparar la concentración medida a una concentración umbral predeterminada que representa la concentración de percentil 99º de la troponina cardiaca en un grupo de individuos normales con un coeficiente de variación (CV) correspondiente del 10% o menos, en donde la concentración umbral es menos de 10 pg/mL; (c) determinar al menos uno de los siguientes en el individuo cuando la concentración de troponina cardiaca es mayor que la concentración umbral: daño cardiaco, daño miocárdico, un evento cardiaco anterior y cardiotoxicidad.
Abstract:
METHODS AND COMPOSITIONS FOR HIGHLY SENSITIVE ANALYSIS OF MARKERS AND DETECTION OF MOLECULES 5OF THE DISCLOSURE Disclosed are methods, kits, and compositions for the highly sensitive detection of molecules. The methods, kits, and compositions are useful in determining concentrations of molecules in samples to levels of 1 femtomolar, 1 attomolar, or lower. The methods, kits, and compositions also allow the determination of concentration over a wide range, e.g., 7-log range, without need for sample dilution. WO 2008/048371 PCT/US2007/008394 Figur IA1 308 307 306 305 Figure 1A
Abstract:
An assay for detecting a detectable species comprising forming a complex between an analyte and a capture species, wherein said capture species is immobilized on a magnetic particle; contacting said complex with a detectable species which specifically binds to said analyte thereby forming an immobilized complex; transferring said immobilized complex to another vessel free of said detectable species; eluting said detectable species from said immobilized complex and detecting said detectable species. Also claimed is a dataset from an assay comprising at least one data point corresponding to a signal from an analyte collected from an assay.
Abstract:
Single molecule analysis of species of use in analytical, diagnostic or prognostic assays is disclosed In exemplary embodiments, the assays utilize samples prepared by the disclosed methods, affording assays of unexpected sensitivity and robustness The method is described in a non-limiting manner by reference to cytokine assays